(Total Views: 911)
Posted On: 11/06/2020 9:13:17 PM
Post# of 153903
Increasing traction/attention/awareness for Leronlimab
NBC 4 News Los Angeles today did a quick story on Leronimab with Dr Otto Yang UCLA Medical. Also interviewed Dr P. also was on. They were talking about compationate use study.
Article in Manila Times today in the Philippines describing efforts to approve Leronlimab in their country
Probably the best article I've seen summarizing Leronlimab and describing the impressive new strategies to rapidly increase s/c trial enrollment, published today on line at InsiderFinancial.com
Article this week in local newspapers Ohio, Texas....
....several hopeful therapeutics and vaccines have shown either low efficacy or restrictive safety issues.
....the virus appears to be globally winning/new numbers are frightening
....we have become aware of a larger population of suffering longhaulers than previously thought
....no bad news for Cytodyn, no rejections, all indications are still on-going and progressing.
NBC 4 News Los Angeles today did a quick story on Leronimab with Dr Otto Yang UCLA Medical. Also interviewed Dr P. also was on. They were talking about compationate use study.
Article in Manila Times today in the Philippines describing efforts to approve Leronlimab in their country
Probably the best article I've seen summarizing Leronlimab and describing the impressive new strategies to rapidly increase s/c trial enrollment, published today on line at InsiderFinancial.com
Article this week in local newspapers Ohio, Texas....
....several hopeful therapeutics and vaccines have shown either low efficacy or restrictive safety issues.
....the virus appears to be globally winning/new numbers are frightening
....we have become aware of a larger population of suffering longhaulers than previously thought
....no bad news for Cytodyn, no rejections, all indications are still on-going and progressing.
(11)
(0)
